Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as C$6.05 and last traded at C$6.03, with a volume of 55,806 shares traded. The stock had previously closed at C$6.00.
Medexus Pharmaceuticals Stock Performance
The stock has a market cap of C$189.50 million, a P/E ratio of -86.14 and a beta of 0.12. The firm has a 50-day moving average price of C$5.04 and a 200-day moving average price of C$4.30.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
